Healthy volunteers bitten by mosquitoes in malaria experiment
NCT ID NCT06607003
First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 8 times
Summary
This study gives healthy adults a controlled malaria infection using donated blood containing the P. vivax parasite. Researchers will monitor how the infection develops, how the immune system responds, and whether mosquitoes can pick up the parasite from participants. The goal is to create a safe model for testing future vaccines and treatments. Participants will take chloroquine to clear the infection and will have follow-up visits for three weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- P. vivax malaria parasite in donated blood
- What this could lead to
- If successful, this could provide a safe model to test future malaria vaccines and treatments, and help understand how the parasite spreads.
- What could go wrong
- This is an early-phase study with only 300 participants, focused on observation, not treatment. Participants will get malaria symptoms and must stay in the clinic for several days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill make your blood deadly to malaria mosquitoes?
- Can a new vaccine stop malaria in its tracks?
- Can a new malaria vaccine slash childhood cases? a massive real-world test seeks answers.
- One shot, six months of malaria shield? a new trial tests a powerful antibody in children
- School health rooms and trained teachers: a new hope for Zambia's children?
- Can a single dose of tafenoquine finally cure vivax malaria in southeast asia?